Stay updated on Cemiplimab in NSCLC: European Clinical Trial
Sign up to get notified when there's something new on the Cemiplimab in NSCLC: European Clinical Trial page.

Latest updates to the Cemiplimab in NSCLC: European Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new history entry 'Revision: v3.3.3' was added and the footer now omits 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.SummaryDifference0.2%

- Check20 days agoChange DetectedAdded new entries for Study Status and Contacts/Locations on 2025-12-09, tied to version 19 from 2025-12-02. These updates reflect the current recruitment status and the study's locations and contacts in the record history.SummaryDifference0.4%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedA new revision v3.3.2 was added and the previous revision v3.2.0 was removed from the Record History for NCT05363319.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoved a site-wide notice about government funding and operating status from the page; it did not affect the core trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check63 days agoChange DetectedVersion 18 (submitted 2025-10-21) was added to the Record History, showing updated study status and contacts/locations. This reflects the latest submission and adds to the version trail.SummaryDifference0.1%

- Check70 days agoChange DetectedNew history entries dated 2025-10-21 and 2025-10-23 update Study Status and Contacts/Locations for NCT05363319. A deletion dated 2025-10-15 removes a prior history entry.SummaryDifference0.4%

Stay in the know with updates to Cemiplimab in NSCLC: European Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cemiplimab in NSCLC: European Clinical Trial page.